You Position: Home > Paper

Study of G1 phase synchronization in endometrial carcinoma HEC-1-A cells

( views:369, downloads:8 )
Author:
No author available
Journal Title:
Cancer Research and Clinic
Issue:
8
DOI:
10.3760/cma.j.issn.1006-9801.2012.08.001
Key Word:
子宫内膜肿瘤;洛伐他汀;HEC-1-A细胞;细胞周期;G1期同步化;Endometrial neoplasms;Lovastatin;HEC-1-A cell;Cell cycle;G1 phase synchronization

Abstract: Objective To investigate the effects of lovastatin on inducing G1 phase synchromzation in HEC-1-A cells and examine the cell cycle progression after desynchronization.Methods The doubling time of HEC-1-A cells was detected by cell counting Kit-8 assay.To determine the best lovastatin concentration of G1 synchronization,HEC-1-A cells were treated with lovastatin at concentration of 10,20,30 and 40 μmol/L respectively for 1 × doubling time,and the cell cycle was detected by flow cytometry (FCM).To determine the best period of lovastatin treatment to achieve G1 synchronization,HEC-1-A cells were treated with lovastatin at the best concentration for 0.5 × to 2 × doubling time,and the cell cycle was detected every 4 h using FCM.Furthermore,the cell cycle progress of HEC-1-A cells after desynchronization was also observed.Results The doubling time of HEC-1-A cells was 24 h.Treated with lovastatin at concentration of 40 μmol/L for 28 h achieved maximum G1 arrest (87.87±0.70) % in HEC-1-A cells.Minimum G1 phase (58.42±0.54) % and maximum S phase (33.58±0.62) % were observed after desynchronizing for 20 h.Conclusion Maximum G1 synchronization of HEC-1-A cells is induced by lovastatin at concentration of 40 μmol/L for 28 h.The HEC-1-A cells show minimum G1 phase and maximum S phase after desynchronizing for 20 h.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn